<\/p>\n
DS\u00d6’den yap\u0131lan yaz\u0131l\u0131 a\u00e7\u0131klamada, Bavarian Nordic’in \u00fcretti\u011fi “MVA-BN\u201d a\u015f\u0131s\u0131n\u0131n, DS\u00d6’n\u00fcn M \u00e7i\u00e7e\u011fi vir\u00fcs\u00fcne kar\u015f\u0131 \u00f6n yeterlilik alan a\u015f\u0131 listesine eklendi\u011fi bildirildi.<\/p>\n
A\u00e7\u0131klamada, \u00f6n yeterlilik onay\u0131n\u0131n, acil ihtiya\u00e7 duyan topluluklarda bu hayati \u00fcr\u00fcne zaman\u0131nda eri\u015fimi kolayla\u015ft\u0131rmas\u0131n\u0131n, bula\u015fmay\u0131 azaltmas\u0131n\u0131n ve salg\u0131n\u0131n kontrol alt\u0131na al\u0131nmas\u0131na yard\u0131mc\u0131 olmas\u0131n\u0131n beklendi\u011fi belirtildi.<\/p>\n
DS\u00d6’ye ba\u011fl\u0131 Ba\u011f\u0131\u015f\u0131kl\u0131k i\u00e7in Uzmanlar Dan\u0131\u015fma Grubu’nun (SAGE) t\u00fcm mevcut kan\u0131tlar\u0131 inceledi\u011fi ve y\u00fcksek maruz kalma riski bulunan ki\u015filer i\u00e7in MVA-BN a\u015f\u0131s\u0131n\u0131n kullan\u0131lmas\u0131n\u0131 \u00f6nerdi\u011fi kaydedilen a\u00e7\u0131klamada, a\u015f\u0131n\u0131n 18 ya\u015f\u0131n \u00fczerindeki ki\u015filerde 4 hafta arayla 2 doz olarak uygulanabilece\u011fi ifade edildi.<\/p>\n
A\u00e7\u0131klamada, MVA-BN’nin \u015fu anda 18 ya\u015f\u0131n alt\u0131ndakiler i\u00e7in lisansl\u0131 olmad\u0131\u011f\u0131 vurgulanarak, a\u015f\u0131n\u0131n bebeklerde, \u00e7ocuklarda, ergenlerde, hamilelerde ve ba\u011f\u0131\u015f\u0131kl\u0131k sistemi zay\u0131f ki\u015filerde “endikasyon d\u0131\u015f\u0131” kullan\u0131labilece\u011fi bildirildi.<\/p>\n
Konuya ili\u015fkin X sosyal medya platformundan payla\u015f\u0131mda bulunan DS\u00d6 Genel Direkt\u00f6r\u00fc Tedros Adhanom Ghebreyesus, bunun hem Afrika’daki mevcut salg\u0131nlar hem de gelecekte hastal\u0131\u011fa kar\u015f\u0131 m\u00fccadele i\u00e7in \u00f6nemli bir ad\u0131m oldu\u011funu belirtti.<\/p>\n
Ghebreyesus, “A\u015f\u0131lara en \u00e7ok ihtiya\u00e7 duyulan yerlerde e\u015fit eri\u015fimi sa\u011flamak i\u00e7in art\u0131k \u00fcretim, tedarik, ba\u011f\u0131\u015f ve da\u011f\u0131t\u0131mda acil bir \u00f6l\u00e7ek art\u0131rmaya ihtiyac\u0131m\u0131z var.” ifadesini kulland\u0131.<\/p>\n
M \u00e7i\u00e7e\u011fi vir\u00fcs\u00fc, fareler ve sincaplar gibi kemirgen hayvanlardan veya enfekte olmu\u015f bireylerden bula\u015f\u0131yor. Vir\u00fcs\u00fcn neden oldu\u011fu v\u00fccut d\u00f6k\u00fcnt\u00fclerine dokunmak, bu d\u00f6k\u00fcnt\u00fclerin bula\u015ft\u0131\u011f\u0131 giysi, \u00e7ar\u015faf, havlu ve benzeri e\u015fyay\u0131 kullanmak ve v\u00fccut s\u0131v\u0131lar\u0131yla temas etmek, en \u00f6nemli bula\u015f nedenleri aras\u0131nda yer al\u0131yor.<\/p>\n
\u0130lk belirtiler, vir\u00fcs\u00fc kapt\u0131ktan sonraki 5 ila 21 g\u00fcnde ortaya \u00e7\u0131kabiliyor. Vir\u00fcs, genelde y\u00fcksek ate\u015f, ba\u015f, s\u0131rt ve kas a\u011fr\u0131s\u0131, lenf bezlerinde \u015fi\u015flik, yorgunluk, \u00fc\u015f\u00fcme, titreme ve ciltte su \u00e7i\u00e7e\u011fine benzer kabarc\u0131klara neden oluyor.<\/p>\n
\u00d6zel bir tedavi y\u00f6ntemi olmayan hastal\u0131\u011f\u0131n tedavisi antiviral ila\u00e7larla yap\u0131l\u0131yor. Vakalar\u0131n b\u00fcy\u00fck k\u0131sm\u0131 hastal\u0131\u011f\u0131 hafif ge\u00e7iriyor ve birka\u00e7 hafta i\u00e7inde sa\u011fl\u0131\u011f\u0131na kavu\u015fuyor.<\/p>\n
DS\u00d6, “maymun \u00e7i\u00e7e\u011fi hastal\u0131\u011f\u0131 (Monkeypox)” ismini, 2022’de \u0131rk\u00e7\u0131l\u0131k ve ayr\u0131mc\u0131l\u0131k kayg\u0131s\u0131yla “mpox” olarak de\u011fi\u015ftirmi\u015fti.<\/p>\n
M \u00e7i\u00e7e\u011fi vir\u00fcs\u00fc, 14 A\u011fustos’ta DS\u00d6 taraf\u0131ndan “uluslararas\u0131 \u00f6neme sahip halk sa\u011fl\u0131\u011f\u0131 acil durumu” olarak ilan edilmi\u015fti.<\/p>\n